Influenza usually lasts days or weeks—but could its effects on the brain last much longer? From von Economo's mysterious encephalitis lethargica to modern research linking severe infections with neuroinflammation and later dementia, scientists are reconsidering the long-term neurologic consequences of infection. The evidence does not prove that influenza causes dementia, but it raises an important question: can infection alter the trajectory of an aging brain?

Could C15:0 (pentadecanoic acid) become the first newly recognized essential fatty acid in nearly a century? Emerging research suggests this naturally occurring odd-chain saturated fatty acid may support healthy cell membranes, mitochondrial function, metabolic health, and healthy aging. Learn what current science tells us about food sources, supplements, recommended intake, and why researchers are paying close attention to this unique nutrient.

Vyepti® (eptinezumab) is a quarterly intravenous treatment designed to prevent migraines before they begin. Unlike daily medications or monthly injections, Vyepti is administered only four times per year and targets CGRP, a key migraine signaling molecule. Learn how this innovative therapy works, who may qualify, what side effects to consider, and the insurance steps often required before treatment can begin. This guide reviews the benefits, risks, and practical consideration